Office-Based Intralesional Steroid Injection for Treatment of Laryngeal Sarcoidosis.
Ann Otol Rhinol Laryngol
; 130(8): 976-979, 2021 Aug.
Article
en En
| MEDLINE
| ID: mdl-33583192
ABSTRACT
OBJECTIVES:
To report preliminary outcomes of a case series of in-office intralesional steroid injections for treatment of laryngeal sarcoidosis.METHODS:
After diagnosis of laryngeal sarcoidosis, 3 patients were offered in-office steroid injections for primary or adjunctive treatment. Triamcinolone 40 was injected into supraglottic sarcoidosis lesions in the office using a channel laryngoscope. Response to treatment and need for further injections was determined based on patient symptoms and repeat flexible laryngoscopy.RESULTS:
In-office intralesional steroid injections provided rapid symptom relief within days that lasted for months, thus decreasing the frequency of operative interventions. For one of the patients in this series, these injections even eliminated the need for tracheostomy. No complications were observed.CONCLUSIONS:
In-office intralesional steroid injection is an emerging adjunctive treatment for laryngeal sarcoidosis. Prospective studies are required to determine efficacy and long-term risk profiles in relation to the current standard of operative management and systemic treatments.Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Sarcoidosis
/
Triamcinolona
/
Enfermedades de la Laringe
/
Atención Ambulatoria
/
Glucocorticoides
Tipo de estudio:
Observational_studies
/
Risk_factors_studies
Límite:
Adolescent
/
Adult
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Ann Otol Rhinol Laryngol
Año:
2021
Tipo del documento:
Article
País de afiliación:
Estados Unidos